LBA56 MEDI5752 or pembrolizumab (P) plus carboplatin/pemetrexed (CP) in treatment-naïve (1L) non-small cell lung cancer (NSCLC): A phase Ib/II trial

Authors :: M-J. Ahn
S-W. Kim
E. Carcereny Costa
L.M. Rodríguez
J. Oliveira
M.A. Insa Molla
M. Majem
L. Costa
W-C. Su
K.H. Lee
J.C-H. Yang
D.R. Spigel
E.K. Cho
M. D'Arcangelo
M.R. Garcia Campelo
A. Delmonte
P. Mitchell
I. Achour
D. Subramaniam
E. Felip
Source :: Annals of Oncology. 33:S1423
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Tools